Dr. Mark Kipnes, MD (he/him) is an Endocrinologist in San antonio, TX with over 16 years of experience. What is your opinion of Dr. Mark Kipnes, MD? Rate this provider below so other people can make informed decision.
Over 16 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Mark Kipnes, MD has received over $32,792 which includes payments from the following companies:
$4,064.12 from Gilead Sciences Inc
$3,600.23 from AstraZeneca Pharmaceuticals LP
$2,314.95 from Novo Nordisk Inc
$1,837.54 from sanofi-aventis U.S. LLC
$1,811.55 from Tandem Diabetes Care, Inc.
$1,450.21 from Medtronic MiniMed, Inc.
$1,358.19 from LILLY USA, LLC
$1,333.87 from Amarin Pharma Inc.
$1,292.49 from Boehringer Ingelheim Pharmaceuticals, Inc.
$1,242.54 from AbbVie, Inc.
$1,095.46 from Janssen Pharmaceuticals, Inc
$1,087.25 from Amgen Inc.
$872.79 from Abbott Laboratories
$807.53 from Merck Sharp & Dohme Corporation
$726.96 from GlaxoSmithKline, LLC.
$712.34 from Radius Health, Inc.
$652.12 from Valeritas, Inc.
$651.38 from MannKind Corporation
$617.23 from Animas Corporation
$440.18 from INSULET CORPORATION
Payments received by Dr. Mark Kipnes, MD were from the following categories:
$25,950.56 Food and Beverage
$4,570.00 Consulting Fee
$1,675.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!